This case study looks at the challenges that arose in a Phase I First In Human trial for the progressive Wilson’s Disease, and how the expert team at Cmed overcame these challenges for the sponsor.
You will learn:
- Critical ways to address the challenge of a novel IMP and complex study design
- Necessary site activities
- Imperative protocol requirements and reviews
Click here to see the case study: Cmed Rare Disease Case Study_Phase I First In Human Study on Wilson’s Disease
